Chinese type 2 diabetes market forecast to reach $2.5 billion in 2014

China’s type 2 diabetes market will increase  from a value of $1.4 billion in 2009 to $2.5 billion in 2014, according to an emerging markets report from advisory firm Decision Resources, which sees attributes this growth to an increasing drug-treated population, expanding medical insurance coverage and the launch and adoption of new drugs in the market.

"China now has the largest type 2 diabetes patient population in the world, and is the third largest market for type 2 diabetes agents, behind the USA and Japan," said Decision Resources analyst Jing Wu, adding: "The type 2 diabetes market in China will continue to grow between 2009 and 2014 at an annual rate of 13%, which is faster than expected growth in the United States or Japan."

New Western drugs will offset generic erosion